<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Stewart L</submitter><funding>NIAID NIH HHS</funding><funding>Infectious Disease Clinical Research Program</funding><funding>National Institutes of Health</funding><pagination>628-636</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7041850</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>185(Suppl 1)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>We examined antibiotic management of combat-related extremity wound infections (CEWI) among wounded U.S. military personnel (2009-2012).&lt;h4>Methods&lt;/h4>Patients were included if they sustained blast injuries, resulting in ≥1 open extremity wound, were admitted to participating U.S. hospitals, developed a CEWI (osteomyelitis or deep soft-tissue infections) within 30 days post-injury, and received ≥3 days of relevant antibiotic (s) for treatment.&lt;h4>Results&lt;/h4>Among 267 patients, 133 (50%) had only a CEWI, while 134 (50%) had a CEWI plus concomitant non-extremity infection. In the pre-diagnosis period (4-10 days prior to CEWI diagnosis), 95 (36%) patients started a new antibiotic with 28% of patients receiving ≥2 antibiotics. During CEWI diagnosis week (±3 days of diagnosis), 209 (78%) patients started a new antibiotic (71% with ≥2 antibiotics). In the week following diagnosis (4-10 days after CEWI diagnosis), 121 (45%) patients started a new antibiotic with 39% receiving ≥2 antibiotics. Restricting to ±7 days of CEWI diagnosis, patients commonly received two (35%) or three (27%) antibiotics with frequent combinations involving carbapenem, vancomycin, and fluoroquinolones.&lt;h4>Conclusions&lt;/h4>Substantial variation in antibiotic prescribing patterns related to CEWIs warrants development of combat-related clinical practice guidelines beyond infection prevention, to include strategies to reduce the use of unnecessary antibiotics and improve stewardship.</pubmed_abstract><journal>Military medicine</journal><pubmed_title>Antibiotic Practice Patterns for Extremity Wound Infections among Blast-Injured Subjects.</pubmed_title><pmcid>PMC7041850</pmcid><funding_grant_id>IDCRP-024</funding_grant_id><funding_grant_id>Y1-AI-5072</funding_grant_id><funding_grant_id>Y01 AI005072-05</funding_grant_id><funding_grant_id>Y01 AI005072</funding_grant_id><pubmed_authors>Tribble DR</pubmed_authors><pubmed_authors>Campbell WR</pubmed_authors><pubmed_authors>Greenberg L</pubmed_authors><pubmed_authors>Krauss M</pubmed_authors><pubmed_authors>Petfield JL</pubmed_authors><pubmed_authors>Stewart L</pubmed_authors><pubmed_authors>Li P</pubmed_authors><pubmed_authors>Blyth MDM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antibiotic Practice Patterns for Extremity Wound Infections among Blast-Injured Subjects.</name><description>&lt;h4>Introduction&lt;/h4>We examined antibiotic management of combat-related extremity wound infections (CEWI) among wounded U.S. military personnel (2009-2012).&lt;h4>Methods&lt;/h4>Patients were included if they sustained blast injuries, resulting in ≥1 open extremity wound, were admitted to participating U.S. hospitals, developed a CEWI (osteomyelitis or deep soft-tissue infections) within 30 days post-injury, and received ≥3 days of relevant antibiotic (s) for treatment.&lt;h4>Results&lt;/h4>Among 267 patients, 133 (50%) had only a CEWI, while 134 (50%) had a CEWI plus concomitant non-extremity infection. In the pre-diagnosis period (4-10 days prior to CEWI diagnosis), 95 (36%) patients started a new antibiotic with 28% of patients receiving ≥2 antibiotics. During CEWI diagnosis week (±3 days of diagnosis), 209 (78%) patients started a new antibiotic (71% with ≥2 antibiotics). In the week following diagnosis (4-10 days after CEWI diagnosis), 121 (45%) patients started a new antibiotic with 39% receiving ≥2 antibiotics. Restricting to ±7 days of CEWI diagnosis, patients commonly received two (35%) or three (27%) antibiotics with frequent combinations involving carbapenem, vancomycin, and fluoroquinolones.&lt;h4>Conclusions&lt;/h4>Substantial variation in antibiotic prescribing patterns related to CEWIs warrants development of combat-related clinical practice guidelines beyond infection prevention, to include strategies to reduce the use of unnecessary antibiotics and improve stewardship.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2025-04-04T02:50:40.749Z</modification><creation>2021-02-20T19:14:14Z</creation></dates><accession>S-EPMC7041850</accession><cross_references><pubmed>32074316</pubmed><doi>10.1093/milmed/usz211</doi></cross_references></HashMap>